Article

Genome-wide CRISPRi screening identifies OCIAD1 as a prohibitin client and regulatory…

medRxiv · 2021 · Le Vasseur, M.; Friedman, J. R.; Jost, M.; Xu, J.; Yamada, J.; Kampmann, M.; Horlbeck, M. A.; Salemi, M. R.; Phinney, B. S.; Weissman, J. S.; Nunnari, J.

Key facts

Title Genome-wide CRISPRi screening identifies OCIAD1 as a prohibitin client and regulatory determinant of mitochondrial Complex III assembly in human cells
First author Le Vasseur, M.; Friedman, J. R.; Jost, M.; Xu, J.; Yamada, J.; Kampmann, M.; Horlbeck, M. A.; Salemi, M. R.; Phinney, B. S.; Weissman, J. S.; Nunnari, J.
Journal medRxiv
Published Feb 17, 2021
DOI 10.1101/2021.02.16.431450
Devices mentioned BK110039, DEN000008, K022086, K103302, K180337, K182970, K800781
Product codes mentioned JCI, KIT, LXG, MNH, MNI, NKB, NDS, NJT, OOI, PFT, KIS, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 10–99 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature